EPISODE 45 | RELEASED April 14, 2020

HER2/neu Osteosarcoma Immunotherapy │ Dr. Sue Ettinger Q&A

Is there a new immunotherapy for dogs with osteosarcoma? Can you get your dog into clinical trials, or is it commercially available?


There is a new immunotherapy treatment in trials for dogs with osteosarcoma, and today Dr. Sue Cancer Vet talks to Leo about it. This new therapy uses the HER2/neu target to stimulate the dog’s own immune system to go after osteosarcoma cells. It’s based on research out of the University of Pennsylvania, and Dr. Sue Ettinger explains a little bit about how it works and how to get Leo’s dog Luke into treatment.

Links Mentioned in Today’s Show:

To find out which veterinary hospitals were involved in clinical trials for the osteosarcoma immunotherapy trials, contact Elanco using their website: https://www.elanco.com/contact

For a summary article about the newest veterinary trials featuring immunotherapy, including the trial discussed in this episode on the HER2/neu target, see this article: https://www.americanveterinarian.com/journals/amvet/2019/january2019/new-veterinary-oncology-therapeutics

Here’s a link to the paper about the initial research on PubMed: https://www.ncbi.nlm.nih.gov/pubmed/26994144

And here’s the press release about her vaccine from the University of Pennsylvania School of Veterinary Medicine: https://www.vet.upenn.edu/about/press-room/press-releases/article/innovative-vaccine-offers-canine-cancer-patients-a-shot-at-a-longer-happier-life

Hosted By




Did You Find This Helpful? Share It with Your Pack!

Share on social media, download a PDF, print this out, or send this in an email to your veterinarian.


Editor's Picks